NICE rejects arthritis drug in draft advice

Golimumab has not been recommended for use in treating psoriatic arthritis, under draft guidance issued by NICE.

Psoriatic arthritis  (Photograph: SPL)
Psoriatic arthritis (Photograph: SPL)

The drug is licensed for use alone, or in combination with methotrexate, for active and progressive psoriatic arthritis in adult patients when previous therapy has been inadequate.

It is also licensed for limited use in the treatment of rheumatoid arthritis and ankylosing spondylitis.

NICE has made the recommendation because research shows golimumab is not more cost-effective than other available options. A spokesman said: 'NICE recommends adalimumab, etanercept and infliximab for the treatment of psoriatic arthritis in people with peripheral arthritis. The cost-effectiveness analyses found that golimumab was not the most cost-effective of the available options currently recommended by NICE.'

A secondary reason for the advice was uncertainty about possible side-effects of the drug, as a long-term follow-up on adverse outcomes is ongoing.

The spokesman added that economic modelling based on evidence about golimumab had shown the drug may be less cost-effective than etanercept, and 'could not be considered a good use of NHS resources'.

The drug's manufacturer MSD said: 'MSD strongly believes that any restrictions on access to this treatment would inhibit patient choice for the treatment of this disabling and chronic disease.'

The draft guidance is open to consultation.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

As the coronavirus crisis continues, we at Haymarket are constantly seeking new ways...

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Around one in four GPs are self isolating - many of them unnecessarily - as frontline...

Cashflow fears for locums as government relaxes 10-week pension rule

Cashflow fears for locums as government relaxes 10-week pension rule

Locums will have longer to declare pensionable income under plans to relax a 10-week...

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs who have retired or no longer hold a licence to practise are...

Updated PHE advice on PPE backs eye protection for GPs

Updated PHE advice on PPE backs eye protection for GPs

GPs should wear eye protection in addition to a mask, gloves and apron when providing...

Repurpose industry now to tackle PPE shortage, says doctors' union

Repurpose industry now to tackle PPE shortage, says doctors' union

UK industry should be 'immediately repurposed' to produce personal protective equipment...